http://www.indiaprwire.com/pressrelease/biotechnology/200804259073.htm
India’s leading knowledge based Life Sciences Company, Avesthagen Limited recently signed a Letter of Intent with Paris based ShigaMediX SAS. The partnership will result in developing a novel therapeutic vaccine against HPV (Human Papilloma Virus), which causes cervical cancer.
